Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication

The protracted global COVID-19 pandemic urges the development of new drugs against the causative agent SARS-CoV-2. The clinically used glycopeptide antibiotic, teicoplanin, emerged as a potential antiviral, and its efficacy was improved with lipophilic modifications. This prompted us to prepare new...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ilona Bereczki, Henrietta Papp, Anett Kuczmog, Mónika Madai, Veronika Nagy, Attila Agócs, Gyula Batta, Márton Milánkovits, Eszter Ostorházi, Ana Mitrović, Janko Kos, Áron Zsigmond, István Hajdú, Zsolt Lőrincz, Dávid Bajusz, György Miklós Keserű, Jan Hodek, Jan Weber, Ferenc Jakab, Pál Herczegh, Anikó Borbás
Format:	article
Language:	EN
Published:	MDPI AG 2021
Subjects:	teicoplanin ristocetin bixin crocetin β-apocarotenoic acid SARS-CoV-2 Medicine R Pharmacy and materia medica RS1-441
Online Access:	https://doaj.org/article/f24dbbab6dc04e6c8e451af15f46c4d7
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication

Similar Items